XTX Topco’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.3K | Buy |
94,054
+50,876
| +118% | +$46.2K | ﹤0.01% | 1912 |
|
|
2025
Q1 | $19.5K | Buy |
+43,178
| New | +$19.5K | ﹤0.01% | 2141 |
|
|
2024
Q3 | – | Sell |
-61,515
| Closed | -$61.3K | – | 2355 |
|
|
2024
Q2 | $61.3K | Buy |
+61,515
| New | +$61.3K | 0.01% | 1485 |
|
|
2024
Q1 | – | Sell |
-27,037
| Closed | -$29.5K | – | 2107 |
|
|
2023
Q4 | $29.5K | Buy |
+27,037
| New | +$29.5K | 0.01% | 1311 |
|
|
2022
Q4 | – | Sell |
-72,807
| Closed | -$82K | – | 1329 |
|
|
2022
Q3 | $82K | Buy |
72,807
+49,255
| +209% | +$55.5K | 0.02% | 978 |
|
|
2022
Q2 | $37K | Buy |
+23,552
| New | +$37K | 0.02% | 773 |
|
|
2022
Q1 | – | Sell |
-13,429
| Closed | -$33K | – | 828 |
|
|
2021
Q4 | $33K | Buy |
+13,429
| New | +$33K | 0.02% | 601 |
|